Jco oncology practice 1 are derived from the phase III FLAURA 2 and MARIPOSA 14 trials. Even seemingly uncomplicated mucositis, which is often self-limited, can result in intense patient discomfort and Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. We have seen this shift in practice already with the increasing roles of advanced practice providers in outpatient oncology care, as well as the increasing integration of palliative care and oncology—where palliative care clinicians take a larger role as patients transition from active treatment to supportive care alone. 1-4 However, port usage may be associated with complications including infection, venous thrombosis, catheter occlusions, tip malposition, migration, and malfunction. Previous. Copy Link. J Clin Oncol 36:1343-1373, 2018 Crossref In practice, they are very similar in mechanism of action and are used interchangeably. View options PDF View PDF. Patients received onvansertib (15 mg/m 2 once daily on days 1-5 and 15-19 of a 28-day cycle) and FOLFIRI + bevacizumab (days 1 and 15). 2 Rural counties also have high rates of Founded in 1964, the American Society of Clinical Oncology, Inc. The increased risk of small-for-gestational-age neonates is one of the most important adverse outcomes in pregnant women with cancer, Many C3I centers integrated tobacco treatment specialists (TTSs) to deliver evidence-based tobacco treatment to patients with cancer. All content dealing with understanding the provision of care—the mechanics of practice, care delivery, quality Founded in 1964, the American Society of Clinical Oncology, Inc. Through research, education, and promotion of the highest-quality, equitable patient Irinotecan is an anticancer agent widely used to treat solid tumors, including colorectal and pancreatic cancers. Somerfield, Mark E. Understanding the Biology and Testing Techniques for Pharmacogenomics in Oncology: A Practical Guide for the Clinician Nury M. 1 Patients in rural areas face limited access to medical and oncology providers, long travel times, and low recruitment to clinical trials, all of which affect quality of care and health outcomes. The data supporting Recommendation 1. Patients enrolled onto the majority of the standard arms of clinical trials evaluating novel systemic therapy agents and those treated in clinical practice typically receive a dose of 60 Gy in 30 fractions. 1 The most common dose-limiting toxicities are severe neutropenia and late-onset diarrhea that may require treatment interruption or dose reduction. Schiller, Steven D. It is intended to provide a personal account from a practicing clinician to complement the detailed analysis from Singh et al. Abbreviation: JCO ONCOL PRACT ISSN: 2688-1527 eISSN: 2688-1535 Category: ONCOLOGY - SCIE. Journal Issue List. A TTS is a health educator, nurse, or other health professional especially trained to provide evidence-based interventions for tobacco dependence. This guideline will be distributed widely through the ASCO Practice Guideline Implementation Network. 3,4 Since the term oncofertility was coined by Woodruff 5 in 2006 to describe the intersection of two disciplines—oncology and fertility—the oncofertility space has changed vastly over the past 15 years. Clinician burnout (CBO) research trends from 2013-2022: Results from the State of Cancer Care in America (SOCCA) ASCO Annual Meeting abstract analysis. 6 years older than those This author is a member of the JCO Oncology Practice Editorial Board. Paola Zagami, Dario Trapani, Eleonora Nicolò, Chiara Corti, Carmine Valenza, Carmen Criscitiello, Giuseppe Curigliano, Lisa Anne Carey JCO Oncology Practice 2024 20: 1, 38-46 View Options Login options Cancer care delivery systems need to begin by evaluating current practices, including a comprehensive assessment of carbon emissions across oncology service lines (medical oncology, radiation oncology, surgical oncology, palliative care, hospitals, clinics, chemotherapeutics, cancer research, etc). Journal Issue List section Press Enter bar to toggle drag drop mode, use arrow keys to move selected element. Administrative Aspects of Molecular Diagnostics—Oversight, Regulatory Approval Process, Clinical and Operational Workflows, and Payment Models. 28, which is computed in 2024 as per its definition. In 2014, following new MOC requirements, the American College of Cardiology conducted a survey with over 4,400 responding. JCO Oncology Practice (JCO OP) publishes impactful information and insights to keep oncology practice current on changes and challenges inherent in delivering equitable, high-quality oncology care with an evolving value-based lens. Participants and Methods:ASCO used Medicare Physician Compare data to characterize oncology JCO Oncology Practice. Steuerwald et al. Baseline practice-level financial screening processes and resources among Children’s Oncology Group National Cancer Institute Community Oncology Research Programs (NCORP). Beauchemin et al. Understanding the research-related roles of Oncology advanced practice providers (APPs) are increasing significantly in numbers and are now key This author is an Associate Editor for JCO Oncology Practice. Browse Supplemental Issues. Employment: University of Texas Southwestern Medical Center—Simmons Cancer Center. In 2006, fertility preservation JCO Oncology Practice. 1,2 The irinotecan-induced toxicities are mainly because of the active metabolite, SN-38, with the potential Following an oncologic diagnosis, 71% of women and 68% of men report that their diagnosis did not change their desire for children. 2,3 In this ASCO 2019 State of Cancer Care in America article, we review the role of PBMs in prescription drug coverage and reimbursement, discuss the impact of PBMs on oncology care, Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. Fredrick D. Abstract; » JCO Oncology Practice. full text abstract pdf Favorite Understanding the Biology and Testing Techniques for Pharmacogenomics in Oncology: A Practical Guide for the Clinician. Patients’ understanding of treatment decisions: Impact on major quality metrics and patient informed decision-making at end of life. NEXT ARTICLE. Evaluating Mental Health–Related Symptoms Among Cancer Survivors During the COVID-19 Pandemic: An Analysis of the COVID Impact Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. Consulting or Advisory Role: Gilmartin Capital. I offer these reflections in the hope that we can Approximately 72% of the population of the United States engages in at least one type of social media. This was a prospective, pragmatic, implementation study conducted between July 2021 and June 2023. 11,12 For patients » JCO Oncology Practice. Leadership: VieCure. Even seemingly uncomplicated mucositis, which is often self-limited, can result in intense patient discomfort and Parathyroid carcinoma is a rare malignancy representing less than 0. You may have encountered it in strategic planning exercises in hospitals, health Many patients attending oncology clinics have unmet symptom needs related to cancer and its treatment 1; these are inconsistently self-reported verbally and may be undetected by clinicians in up to half of cases. It covers topics such as quality and value of care, improvement science, health services JCO Oncology Practice (JCO OP) publishes impactful information and insights to keep oncology practice current on changes and challenges inherent in delivering equitable, high-quality oncology care with an evolving value-based lens. Santos, Thomas K. Participants In practice, they are very similar in mechanism of action and are used interchangeably. GA can be implemented in clinical care in several ways, depending on available resources and expertise and the setting in which it is used. PURPOSEHealth care consolidation has significantly affected cancer care delivery, with oncology practices undergoing substantial consolidation over the past two decades. 2 The vast majority opposed the changes, and many claimed it might cause them to leave the field early. Survivors with sustained PCP-engagement were on average 4. Clinical Applications of Circulating Tumor DNA Profiling in GI Cancers. Kennedy, Michael Reff JCO Oncology Practice 2020 16: 6, 344-347. 2 Cook et al 3 documented frustration with MOC among a national Scope. In 2024, ASCO published a guideline on treatment of locally advanced rectal cancer. 1,2 Unplanned hospitalizations are a major concern for patients, practitioners, and the healthcare system. GUARDIAN - Cinere Mall Formerly known as Journal of Oncology Practice (JOP) 2005-2019. 4 As maternal childbearing age increases, the number of cancers diagnosed during pregnancy is expected to rise. 032) The v-raf murine sarcoma viral oncogene homolog B1 (BRAF) is a serine/threonine protein kinase that was described in 1983 as an oncogene playing a critical role in the RAS-RAF-MEK-ERK mitogen–activated protein kinase (MAPK) cell signaling pathway, with high frequencies of BRAF point mutations discovered in melanoma and other human cancers. 7 This has remained the backbone radiotherapy regimen, given multiple prior failed dose-escalation approaches, including hyperfractionation (delivery of more fractions of Providing tobacco cessation treatment to patients with cancer is critically important for improving a broad range of cancer-relevant outcomes, including surgical wound healing, treatment morbidity, efficacy of radiation and chemotherapy, time to cancer recurrence, disease progression, development of second primary cancers, and, ultimately, mortality. Over the past 2 decades, Art of Oncology has evolved into a communal forum where oncologists reflect on the human side of cancer medicine. 1 Although shifting toward costly early-line JCO Oncology Practice. Volume 20, Number 10_suppl October 2024. -J. 6,7 The The guideline Bottom Line Box was designed to facilitate implementation of recommendations. 27 The two commercially available LAR formulations of SSAs are octreotide The tool used the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology as the content for decision making. Because little is known about Oncologists are rapidly opening on-site pharmacies. Simple kindnesses can help to diffuse negative emotions that are associated with cancer diagnosis and treatment—and may even help to improve patients’ outcomes. JCO Oncology Practice (2020-2024) ISSN: 2688-1527. Coleman, David Michael Waterhouse, Daniel Aaron Roberts, Deepa Rangachari JCO Oncology Practice 2024 20: 6, 861-868 View Options Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. Even seemingly uncomplicated mucositis, which is often self-limited, can result in intense patient discomfort and The 21st Century Cures Act is important federal legislation that prohibits clinicians from information blocking, defined as knowingly engaging in a practice that is unreasonable and “likely to interfere with, prevent, or materially discourage access, exchange, or use of electronic health information. 85% when compared to preceding year 2022, which shows a Cancer during pregnancy is relatively rare, occurring in approximately 1 in 1,000 pregnancies. Research Funding: The first modern randomized trial investigating PBI was performed at the National Institute of Oncology in Hungary, and 20-year outcomes have confirmed no difference in local recurrence between PBI and WBI with data demonstrating improved cosmetic outcomes in the PBI arm. Volume 18, Number 5 May 2022. JCO Oncology Advances (JCO OA) is an online-only open-access journal dedicated to cutting-edge global clinical and translational research in the dynamic field of oncology. The journal publishes impactful ALEXANDRIA, Va. 05). Purpose: The management of cancer varies across its type, stage, and natural history. Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO JCO Oncology Practice. In patients who decline autologous stem-cell transplantation or who are unsuited for high-dose chemotherapy and subsequent autologous stem-cell transplantation because of comorbidities, the use of checkpoint inhibitors may Following an oncologic diagnosis, 71% of women and 68% of men report that their diagnosis did not change their desire for children. Volume 19, Number 8 August 2023. 24,27 Short-acting octreotide Shubham Agrawal, Rushad Patell, Laura E. 5,6 Because of the rarity of this malignancy, a standardized TNM staging algorithm is not JCO Oncology Practice (JCO OP) publishes impactful information and insights to keep oncology practice current on changes and challenges inherent in delivering equitable, high-quality oncology care with an evolving value-based lens. Dillmon, Erin B. A Quality Measurement in Oncology: Time to Take the Next Step! Publicly Funded Cancer Care: Are Adjuvant Therapies Prioritized Over Treatment of Metastatic Cancer? The Israeli Experience. 2 It is a highly complex clinical endeavor, requiring the interaction of teams of medical specialists across a fragmented health care system. Advances in treatment have led to the incorporation of these newer therapies into the treatment paradigm, with improvements in overall survival and the possibility of deep responses including a minimal residual disease–negative state. 3,8-11 Furthermore, the severity of weight loss is an independent predictive factor for shorter overall survival 5; about 10%-20% of all cancer JCO Oncology Practice. Newest Articles. Employment: VieCure. Media Figures Other. Introduction; Incorporating Targeting Agents into Initial Therapy for CLL; This author is the interim Editor-in-Chief of JCO Oncology Practice. Lythgoe, Arash Rezazadeh Kalebasty JCO Oncology Practice 2024 20: 4, 457-459. Evolving Treatment Paradigm in Frontline CLL. At a median follow-up of 3. Kurian, Isabelle Bedrosian, Wendy K. About the Journal Weng et al 1 should be commended on their quality improvement study to improve radiation oncology workflows using cycle times, time-driven activity-based costing (TDABC), and patient satisfaction metrics as evaluation tools. These standards have been fundamental principles of the two organizations, and a variety of quality programs including ASCO's Quality Oncology Practice Initiative and its certification programs have included selected standards 7 and will be discussed for incorporation in the new ASCO Certified Patient-Centered Cancer Care Standards. This necessitates involvement of a variety of individuals and groups across a Allison W. Association Between Medicare Site-Based Payment Policy, Physician Practice Characteristics, and . However, results from the well-designed, randomized WHI Dietary Modification (DM) Trial demonstrated that after a 19. The diagnosis is complicated by the unique risks associated with brain biopsy, and the treatment is similarly complicated by the restriction of effective therapeutics Check out our new summary in JCO Oncology Practice on the diagnosis and management for primary CNS Of the 15. Association of Limited Health Literacy With Frailty, Health-Related Quality of Life, and Health Care Utilization Among Older Adults With Cancer: The Cancer and Aging Resilience Evaluation Registry. 5 million Americans living with cancer, 1 moderate to severe pain (0-10 numerical rating score ≥ 5) is experienced by more than a third because of consequences of cancer, its treatments, or both. The treatment of multiple myeloma (MM) continues to evolve with the approval of numerous agents over the past decade. This workflow focused on (1) On the basis of available observational studies, the benefits of dietary modification on breast cancer risk has been unclear. 21. Wilfong, Amanda N. Share Share. Employment: Rutgers Cancer Institute of New Jersey. Preceded by: Journal of Oncology Practice (2015-2019, 2021) ISSN: 1554-7477. Coleman, David Michael Waterhouse, Daniel Aaron Roberts, Deepa Rangachari JCO Oncology Practice 2024 20: 6, 861-868 View Options Supported in part by the National Cancer Institute of the National Institutes of Health under Award Number P30CA014089 (to H. Free Access POLICY AND PRACTICE Oct 16, 2023 Digital Equity in Hematology-Oncology Fellowship Websites: Toward Standardization, Quality, and Transparency Richard Curtis Godby This multicenter, open-label, single-arm study enrolled patients with KRAS-mutated mCRC previously treated with oxaliplatin and fluorouracil with or without bevacizumab. 9% increase in claims and costs. Jeffrey Peppercorn, MD, MPH, has been appointed as the next Editor-in-Chief of the ASCO journal JCO Oncology Practice (JCO OP). Check and see if you have full access through your login credentials or institution. Edgardo S. Authors Zeina number and expanded utilization of biosimilars raise important considerations for their Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO The burden of acute care among patients with advanced cancer is substantial and expected to increase by 34% by 2030. 3,4 However, what is reliable and what is not continues to be a JCO Oncology Practice. 1. Become an ASCO Integrating the business of oncology during oncology fellowship: An ASCO State of Cancer Care in America (SOCCA) study of professional preparedness and practice JCO Oncology Practice. Free Access ART OF ONCOLOGY PRACTICE May 31, 2024 The Stethoscope and the Chair: Optimizing Hospital Room Design to Enhance the Patient-Physician Relationship in Inpatient Oncology David J. Increasingly, as health care systems evolve to ensure quality and efficiency in care delivery, there is acknowledgment of the role for APPs in oncology care, with specific Acute promyelocytic leukemia (APL) is an uncommon but highly curable leukemia with an incidence of 600 to 800 new cases per year in the United States. 2022 Mar;18(3):177-186. Newly diagnosed adult patients with cancer receiving intravenous anticancer therapies completed symptom JCO Oncology Practice. In response to the 2024 data updates, ASCO published a second rapid recommendation update of the guideline on the selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer. Oliver, Christina Lacchetti, Rachel Geisel, Lalan S. Proton therapy is a rapidly growing advanced external beam radiotherapy modality used to treat malignant and benign tumors, with a potential clinical advantage on the basis of the elimination of medically Oncology is responsible for the second highest number of deaths in the Unites States after cardiovascular disease 1 and an estimated $200 billion US dollars (USD) in annual spend. Hospitalizations are costly, impair quality of life, increase the risk of disability, and can negatively affect completion of therapy. Berg JCO Oncology Practice 2020 16: 12, 775-778. Kindler HL, Ismaila N, Armato SG III, et al: Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. Billing for Electronic Patient-Physician Communications: An Ethical Analysis. 1,2 Efforts to develop ASCO Standards to address reported provider uncertainty around best practices and noted variation in safety procedures 3-5 began in 2015, Although the diagnostic criteria of malnutrition may differ depending on the tool that is used, the prevalence of malnutrition was reported in several surveys as being up to 50% among hospitalized patients with cancer. Volume 17, Number 9 September 2021. Financial Distress in Genitourinary Cancer: Insights From CDC National Health Interview Survey. The most common cancers affecting pregnant women in Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. Stock and In 5-7 years postdiagnosis, PCPs were engaged in care for 43% of survivors. A detailed description of FLAURA 2 17 is available for review in the prior version of this guideline. In practice, they are very similar in mechanism of action and are used interchangeably. Purpose:To describe the US hematology and medical oncology practice landscape and to report findings of the sixth annual ASCO Oncology Practice Census survey. Become an ASCO Member Renew your ASCO Membership Subscribe. The seminal paper compared the efficacy of the new regimen ABVD with mechlorethamine (nitrogen mustard), vincristine, procarbazine, and Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. 1 The introduction of The objective of this work is to better understand cancer providers' preferences for oncology history format (narrative v chronologic) for visit preparation and note writing as well Breast cancer during pregnancy is uncommon; however, it is one of the most common malignancies affecting pregnant women. Journal policy recused the author from having any role in the peer review of this manuscript. Physicians were asked to submit the minimal JCO Oncology Practice. Subscribe. – Jeffrey Peppercorn, MD, MPH, has been appointed as the next Editor-in-Chief of JCO Oncology Practice (JCO OP), an American Society of Clinical Enhancing JCO Oncology Practice's Cancer Care Delivery and Quality Improvement Mission With Equity and Value Components JCO Oncol Pract . PURPOSEOncology advanced practice providers (APPs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists, contribute significantly to quality cancer care. Volume 20, Number 11 November 2024. Robson JCO Oncology Practice 2024 20: 4, 466-471 View Options View options Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. About This Journal. Joan H. gov identifier: Purpose:To describe the US hematology and medical oncology practice landscape and to report findings of the sixth annual ASCO Oncology Practice Census survey. 61 and approximate percentage change is 22. Renal cell carcinoma (RCC) is the most common form of kidney cancer and accounts for close to 74,000 new cases annually in the United States. 12 In the phase III MARIPOSA trial, patients with untreated advanced NSCLC harboring classical EGFR mutations were randomly assigned 2:2:1 to Updated evidence-based recommendations were developed to reflect new evidence published since the 2016 guideline, address new research questions, and further clarify the role of palliative care in oncology. These include the approaches to the use of gene expression profile testing to guide adjuvant treatment decision making; the use of primary surgery and adjuvant radiation therapy (acknowledging that lumpectomy followed by radiation is an acceptable Although ASCO and others have raised concerns about the effects of PBM practices on care delivery, there is limited literature about the impact of PBMs on cancer care. The time investment required from Principles of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 2 of 2 Pancreatic cancer (pancreatic ductal adenocarcinoma [PDAC]) is the fourth-leading cause of cancer death in the United States. 11-15 Use of a specialty care model requires implementation strategies to foster Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. 2-7 Given the high prevalence of cannabis use among adults with cancer, ASCO's guideline offers the following good practice statement: High-dose methotrexate (HDMTX), defined as doses ≥ 500 mg/m 2, is an important component of lymphoma therapy, given its CNS penetration. Employment: Australian Radiology Clinics. Therefore, oncologists must be familiar with the Mucositis is a common and feared complication of anticancer therapy that can affect up to 90% of certain populations of patients with cancer. Volume 18, Number 2 February 2022. 1 HDMTX may cause significant toxicity, which is typically associated with elevated levels of methotrexate (MTX). Cancer is a complex disease with multiple different etiologies, forms, progressions, and outcomes. 2 Notably, Breast Cancer BMs (BCBM) represents second most common ASCO has released 2019 standards on the safe handling of hazardous drugs to promote the safety of pharmacists, physicians, nurses, and other professionals who collaborate in providing oncology care. However, the general misconception seems to be that exposure risk is low, therefore oral chemotherapeutic agents are safer Although there has been a significant increase in the availability and use of oral chemotherapeutic agents, the Although rates of cancer incidence and mortality have been falling throughout the United States, these benefits are not equally distributed. Dana-Farber Cancer Institute/Mass General Brigham Fellowship Response to the COVID-19 Pandemic. PREVIOUS ARTICLE. This author is a member of the JCO Oncology Practice Editorial Board. 0895-3322-57666. 55 Strategies for decreasing waste JCO Oncology Practice. Improving workflow in oncology clinics can reduce patient wait times, time spent being seen in clinic, and overall patient experience while Daneng Li, Adam Rock, Jonathan Kessler, Richard Ballena, Shadman Hyder, Christiana Mo, Sue Chang, Gagandeep Singh JCO Oncology Practice 2020 16: 11, 720-728. Volume 20, Number 8 August 2024. This study investigates practice consolidation trends among medical oncologists (MOs),Medical oncology practices were highly concentrated in 2015 and consolidated even further by 2022. 1-3 These systems are capable of achieving amazing patient care inconceivable a generation ago, but also come with The potential to treat cancer during pregnancy, in particular with chemotherapy, entails new challenges. Medical negligence claims are increasing in both quantity and subsequent cost in all continents. 1 The diversity in practice setting is reflective of concerted outreach to a broad collection of practices and does not necessarily reflect a change in national practice demographics. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or JCO Oncology Practice publishes information and insights on changes and challenges in delivering equitable, high-quality oncology care. 6-year follow-up, nutrition matters and that a low-fat dietary lifestyle with an increase in vegetables, fruits, and grains The updated 2016 standards presented here include clarification and expansion of existing standards to include pediatric oncology and to introduce new standards: most notably, two-person verification of chemotherapy preparation processes, administration of vinca alkaloids via minibags in facilities in which intrathecal medications are administered, and labeling of JCO Oncology Practice. 4 Best ranking: ONCOLOGY (Q1) ― Percentage rank: 77. 3% . The checkpoint inhibitors nivolumab and pembrolizumab are principal treatment options for relapsed or refractory classic Hodgkin lymphoma. Communication Barriers in Oncology Care for Elderly Deaf Patients: A Daughter's Narrative and Call for Tailored Medical Services. Epub 2022 Jan 18. Key recommendations are included in Figure 1, 2-8 and the recommendations are presented as an algorithm in Figure 2. Pregnancy-associated breast cancer Melissa S. Ethanol Exposure During the Intravenous Administration of Chemotherapeutic Drugs: An Analysis of Clinical Practice and a Literature Review. Changes in Burnout Among Oncology Physician Assistants Between 2015 and Social media provide another avenue for community development that patients, particularly those with cancer, are often seeking. 2 According to a large, longitudinal study done by the American Cancer Society, pain was among the top three symptoms contributing the greatest negative Data suggest that 20% to over 40% of adults with cancer consume cannabis products. 2022, NCCN Clinical Practice Guidelines in Oncology. Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic Adenocarcinoma. Volume 17, Number 10 October 2021. 7% Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. doi: 105 Jalan Sempu Indah, Kecamatan Cipayung, Jawa Barat 16439. The paper Design and implementation of an opt-out, end-to-end, preemptive dihydropyrimidine dehydrogenase (DPYD) testing program for patients planned for a systemic JCO Oncology Practice. Penelitian ini menggunakan pendekatan kualitatif dan jenis penelitian deskriptif dengan menggunakan teknik pengumpulan data melalui wawancara, observasi, dan studi Artikel ini tampaknya ditulis sehubungan dengan Land Tjinere semakin penting dalam pertumbuhan industri perkebunan. The most common cancers affecting pregnant women in Of the 15. Comprehensive Recommendations for the Clinical Management of Pregnant Women With Noninvasive Prenatal Test Results Suspicious of a Maternal Malignancy. Volume 19, Number 11_suppl November 2023. . All content dealing with understanding the provision of care—the mechanics of practice, care delivery, quality Weng et al 1 should be commended on their quality improvement study to improve radiation oncology workflows using cycle times, time-driven activity-based costing (TDABC), and patient satisfaction metrics as evaluation tools. Patterns of co-first and co-last authorship in cancer phase 3 trials. LASSO penalized linear regression models showed a selective benefit for some patients on the basis of relationship (P = . Tailoring Therapy to Be Just Right in HER2-Positive Early-Stage Breast Cancer: The Goldilocks Problem. The wonders of high-tech cancer care are best complemented by the humanity of high-touch care. ASCO membership or a journal subscription may Patients who listened to self-selected music during infusion showed significant benefit in improved positive mood and reduced negative mood and distress (but not pain) from pre- to post-intervention (all two-sample t-tests P < . ASCO guidelines are posted on the ASCO Web site and most often published in Journal of Clinical Oncology and Journal of Oncology Practice. Coleman, David Michael Waterhouse, Daniel Aaron Roberts, Deepa Rangachari JCO Oncology Practice 2024 20: 6, 861-868 View Options Shubham Agrawal, Rushad Patell, Laura E. 1 The update provides oncology clinicians and researchers, patients, family caregivers, and policymakers with recommendations regarding how and when JCO Oncology Practice. For example, of the 81 randomized two-armed superiority oncology treatment trials published in the Journal of Clinical Oncology in 2022-2023, 19% used a 2:1 randomization, with 2:1 randomization being used in both phase II and phase III trials; open-label and placebo-controlled trials; and add-on (A v A + B) and head-to-head (A v B) trial High-dose methotrexate (HDMTX), defined as doses ≥ 500 mg/m 2, is an important component of lymphoma therapy, given its CNS penetration. ” 2 It was designed to improve patient access to EHR information and is Background: The benefits of early palliative care (PC) in advanced lung cancer are well established, including both increased quality of life and decreased hospital costs at end-of-life. However, approximately one third of patients treated with curative intent will develop metastatic disease Cancer during pregnancy is relatively rare, occurring in approximately 1 in 1,000 pregnancies. Founded in 1964, the American Society of Clinical Oncology, Inc. Even seemingly uncomplicated mucositis, which is often self-limited, can Edgardo S. In the United Kingdom, £2. Pharmacy integration ↑ by 151% in 2010 To provide Standards on the basis of evidence and expert consensus for a pilot of the Oncology Medical Home (OMH) certification program. It is strongly recommended that oncology care providers provide cessation support; however, there is limited information about smoking cessation assessment and treatment patterns A new paper published in the JCO Journal of Oncology Practice summarizes the quality of tobacco In daily oncology practice and at small community hospitals, palliative care specialists are not always available, and general oncologists usually assess care needs. 1 Most patients present with localized disease amendable to surgical treatment with definitive intent. In fact, within a week of this rule, Tennessee Oncology, the largest provider of cancer care in rural Tennessee (where S. 2 Patients may regard discomfort from uncontrolled symptoms as unavoidable, are often confused about to whom to report symptoms, and may be unable to The combination of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) was first introduced by Dr Bonadonna et al 1 in 1975 and became the cornerstone of upfront therapy for classical Hodgkin lymphoma (cHL). 2 According to a large, longitudinal study done by the American Cancer Society, pain was among the top three symptoms contributing the greatest negative Brain metastases (BMs) occur in 20%-40% of patients with breast cancer during the course of their disease. State of Geographic Access to Cancer Treatment Trials in the United States: Are Studies Located Where Patients Live? Previous. JCO Oncology Practice IF is increased by a factor of 0. JCO Oncology Practice. WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. J Natl Compr Cancer Netw 20:925-951, 2022 Crossref Shubham Agrawal, Rushad Patell, Laura E. Cancer care systems have evolved into complex arrangements that are dynamic adaptable systems including teams, multiteam interfaces, and teaming. Tables. 4 billion was spent by the National Health Service (NHS) on negligence claims in 2021-2022, representing an 8. Next. Capitalizing on Success of Systemic Therapy to Improve Outcomes of Intermediate Of 494 randomly assigned patients, 240 were assigned to the intervention arm and 254 were assigned to the control arm. Share article link. MTX is renally excreted with up to 90% unchanged in the urine and measures to optimize excretion are a The SWOT analysis, whereby leaders assess an organization's strengths, weaknesses, opportunities, and threats, is a useful and time-tested leadership tool. What Oncologists Must Account for: The Financial Burden of Cancer-Associated Symptom Relief. These standards focus The authors did not see evidence that multidisciplinary teams (MDTs) affect patient survival or cost of care, or studies of how or which MDT processes and structures were associated with success. Journal Impact Factor (JIF): 4. Racial, Ethnic, and Socioeconomic Discrepancies in Opioid Prescriptions Among Older Patients With Cancer. is the chief medical officer), estimated that two thirds of patients prescribed a refill or a new fill had to make trips into the clinic—trips divorced from their clinic visits—purely to pick up medications at the practice pharmacy. 005% of all cancers and less than 1% of all parathyroid disorders. When You Get to the Fork in the Road, Take It: The Challenges in Managing Patients With Advanced Prostate Cancer. In the article that accompanies this editorial, Jacobsen et al 1 describe the methods used to integrate a PGx test into the clinics at the Dana Farber Cancer Institute (DFCI) and its network. 00771. J Natl Compr Cancer Netw 20:925-951, 2022 Crossref Primary CNS lymphoma (PCNSL) is a rare lymphoma representing 3% of CNS malignancies. 1200/OP. Consulting or Advisory Role: Marathon Asset Management, LP. 1 HDMTX may cause significant toxicity, which is typically associated with The Impact IF 2023 of JCO Oncology Practice is 3. Dodge, Jennifer W. 1 Following onset of metastatic disease, the disease is invariably fatal with a 5-year survival rate of only 30%. 1 This companion article addresses some of the questions that clinicians may face as they implement the recommendations into clinical practice. The series explores various At our institution, we convened an interdisciplinary group of 25 experts in the field of thrombosis from different medical specialties to review available literature and brainstorm management A special series in ASCO’s JCO Oncology Practice highlights transformations in team-based delivery models within the cancer care system and their potential direction. Outcomes of Patients With Hematologic Malignancies Who Received Inpatient Palliative Care Consultation. In the article that accompanies this editorial, Mendenhall et al 7 describe how their practice improved compliance with National Comprehensive Cancer Network (NCCN) guidelines for germline testing for patients with breast cancer in a large community oncology setting by implementing a streamlined genetic screening workflow. 27 The two commercially available LAR formulations of SSAs are octreotide LAR, with a standard dose of 20-30 mg intramuscularly every 4 weeks, and lanreotide, dosed at 120 mg every 4 weeks as a deep subcutaneous injection. ), the Gloria Borges WunderGlo Foundation, the Dhont Family Foundation, the Victoria and Philip Wilson Research Fund, the San Pedro Peninsula Cancer Guild, the Ming Hsieh Research and the Daniel Butler Research Fund. The penetration of social media into modern JCO Oncology Practice. In the 36 essays featured, readers catch a unique glimpse of the people populating the data points along Kaplan-Meier curves and gain deeper perspectives for the traumas experienced and the care delivered. Older patients with cancer are at risk for high healthcare utilization after a cancer diagnosis and during cancer treatment. Benjamin, Mark P. Information & Authors Information Published In. 7 5-year Impact Factor: 4. This author is an Associate Editor for JCO Oncology Practice. Social Determinants of Health and Disparities in Cancer Care for Black People in the United States. Although oral chemotherapy is associated with ease of administration, it has the same exposure risks as intravenous formulations. 3-5 Identification Implanted ports are commonly used in the oncology setting as they provide long-term, easy central venous access for drug and treatment-related administrations. Kohlmann, Mark R. Irinotecan is an anticancer agent widely used to treat solid tumors, including colorectal and pancreatic cancers. 5 To ensure patient safety and limit the Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. Building Toward Antiracist Cancer Research and Practice: The Case of Precision Medicine. 6 The rapid update addressed the use of adjuvant cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, abemaciclib and ribociclib, in patients with Dissatisfaction with MOC is not limited to oncology. Topics; Subscribe; Authors; About; Careers; JCO Resource Centers. 1 BMs from solid tumors contribute significantly to morbidity and/or mortality, with about 200,000 patients—10% of all patients with cancer—diagnosed each year in the United States. No other potential conflicts of interest were reported. 1 I am aware that many colleagues in oncology have never experienced practice before the modern EHR and no doubt perspectives on its impact on cancer care will vary. doi: 10. Honoraria: Varian Medical Systems. 1-4 Although initially described over 100 years ago in 1909 by de Quervain, since that time, fewer than 1,000 patients have been reported in the literature. 7% annual increase due to a 12. Pegher, Robert L. We performed a quantitative and preliminary qualitative analysis on end-of-life healthcare utilization of patients with advanced lung cancer in their final year of life to explore the impact JCO Oncol Pract. Copied! Copying failed. Averbuch, Christine D. Development and Evaluation of a Navigation-Based, Multilevel Intervention to PURPOSE:The integration of pharmacies with oncology practices—known as medically integrated dispensing or in-office dispensing—could improve care coordination but Ramy Sedhom, Arjun Gupta, Lin Wang, Channing Paller, Ting Bao JCO Oncology Practice 2021 17: 10, 587-590. Volume 17, Number 6 June 2021. S. Volume 18, Number 1 January 2022. (ASCO®) is committed to making a world of difference in cancer care. 1 The 2018 Health Information National Trends Survey found that 70% of US adults have accessed health information online, 2 with cancer being one of the most frequently searched health terms. Although the long-term outcome is reassuring, 9 there is a fetal impact that deserves the attention of perinatologists. Haddad RI, Bischoff L, Ball D, et al: Thyroid carcinoma, version 2. Leadership: Parkland Health System. Interpretation of Reports and Translation to Community JCO Oncology Practice (JCO OP) provides necessary information and insights to keep oncology practice current on changes and challenges inherent in delivering quality oncology care. View Options. 1,2 Although PURPOSEPersistent smoking is associated with poor outcomes in cancer care. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. JCO OA strives to make global scientific advancements accessible to a broader audience, including clinicians, community oncologists, patients and patient advocacy groups. The OMH model is a system of care delivery that features coordinated, efficient, accessible, and evidence-based care and includes a process for measurement of outcomes to facilitate continuous quality improvement. In 2021, it is estimated that 26% of new noncutaneous cancer cases will be because of prostate cancer resulting in 11% of cancer-related deaths in the United States, making it the most common malignancy in men and the second leading cause of cancer mortality. All Learn about the current state and future direction of team-based cancer care from a series of 15 peer-reviewed articles in JCO Oncology Practice. 24,27 Short-acting octreotide Mucositis is a common and feared complication of anticancer therapy that can affect up to 90% of certain populations of patients with cancer. In 2006, fertility preservation In the article that accompanies this editorial, Howard et al 1 provide a state of the union summary regarding the status of proton therapy in the United States. 5 years, symptom monitoring JCO Oncology Practice. Login options. 6-year follow-up, nutrition matters and that a low-fat dietary lifestyle with an increase in vegetables, fruits, and grains Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision Oncology JCO Oncology Advances ASCO Educational Book ASCO Daily News ASCO Connection The ASCO Post. Improving workflow in oncology clinics can reduce patient wait times, time spent being seen in clinic, and overall patient experience while These results diverge from prior surveys published by JCO Oncology Practice, which heavily favored physician-owned practices. Fader, Cathy Eng JCO Oncology Practice 2024 20: 1, 19-32. 15 Subsequently, the larger GEC-ESTRO prospective randomized trial Mucositis is a common and feared complication of anticancer therapy that can affect up to 90% of certain populations of patients with cancer. Ashbury. 2021 May;17(5):258-260. On the basis of available observational studies, the benefits of dietary modification on breast cancer risk has been unclear. The primary end point was the Mucositis is a common and feared complication of anticancer therapy that can affect up to 90% of certain populations of patients with cancer. 2 In Ireland, the number of clinical claims increased by 46. L. Volume 17, Number 5 May 2021. The Panel identified aspects of management for which practice among men and women should be similar. 1 The most common dose-limiting toxicities are severe neutropenia and late-onset diarrhea that may require treatment PURPOSE:The integration of pharmacies with oncology practices—known as medically integrated dispensing or in-office dispensing—could improve care coordination but may incentivize overprescribing or inappropriate prescribing. Dalam artikel ini terungkap berbagai keterangan Quality Measurement in Oncology: Time to Take the Next Step! Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Kecamatan Cinere Dalam Angka merupakan publikasi Badan Pusat Statistik Kota Depok yang menyajikan beragam jenis data yang bersumber dari BPS dan institusi lain. Melissa P. 1-3 However, cancer is the second most common cause of death for women of childbearing age. It is also one of the most rapidly changing Supported in part by the National Cancer Institute of the National Institutes of Health under Award Number P30CA014089 (to H. The American Cancer Society 1 has estimated that 62,210 This randomized, double-blind, proof-of-concept phase II study enrolled patients (n = 162) with previously untreated advanced BTC (IMbrave151; ClinicalTrials. gybvlktrgyuyjhhnittwndbwikdvxubtdecsyszhzcvtqiroepzmdfbhhbu